Cell & Gene Collaborative Blog

81. “Ancillary Materials” 10/27/2021

    Question: What do you get when ARW surfs the Internet? Answer: The best the internet has to offer. Duh
82. Is The CGT Industry Too Diluted To Sustainably Scale Manufacturing? 10/25/2021

    Every year around this time, I have the infamous — but nevertheless enjoyable — “crystal ball” conversation with executives for the outlook edition of Life Science Leader magazine. As you can imagine, crystal ball-style questions are exceptionally fun in the CGT industry, which changes shape as quickly as a sand dune in a hurricane. Thankfully, Robert Hariri, M.D.,Ph.D., CEO and Chairman of Celularity, was more than willing to answer my questions, and he spared no enthusiasm in doing so.

83. “Ancillary Materials” 10/14/2021

    Without fail, the Internet has once again delivered the goods we probably didn’t really need — but never say never...

84. Is This One Solution To The AAV Gene Therapy Full/Empty Capsid Dilemma? 9/21/2021

    It was a tragic headline to read: “Fourth Boy Dies In Astellas-Audentes Gene Therapy Trial, Raising Fresh Fears For The Field.”

85. Living Happily Ever After With Your Cell Therapy Facility: Managing Innovation & Your COGS 9/20/2021

    In recent months, I watched an Endpoints News webinar entitled, “Strategies For Building A Cell Therapy Manufacturing Facility.” The webinar, which included executives from Tenaya Therapeutics, Iovance, Kite Pharma, and Instil Bio, provided some great considerations and best practices for those of you who have chosen to take the plunge into building your own capacity.

86. Living Happily Ever After With Your Cell Therapy Facility: The “Design Of Your People” Also Matters 9/20/2021

    In recent months, I watched an Endpoints News webinar entitled, “Strategies For Building A Cell Therapy Manufacturing Facility.” The webinar, which included executives from Tenaya Therapeutics, Iovance, Kite Pharma, and Instil Bio, provided some great considerations and best practices for those of you who have chosen to take the plunge into building your own capacity.

87. Living Happily Ever After With Your Cell Therapy Facility: The If's & When's Of Expansion 9/20/2021

    In recent months, I watched an Endpoints News webinar entitled, “Strategies For Building A Cell Therapy Manufacturing Facility.” The webinar, which included executives from Tenaya Therapeutics, Iovance, Kite Pharma, and Instil Bio, provided some great considerations and best practices for those of you who have chosen to take the plunge into building your own capacity.

88. Living Happily Ever After With Your Cell Therapy Facility: How To Plan For A Make-To-Order Model 9/20/2021

    In recent months, I watched an Endpoints News webinar entitled, “Strategies For Building A Cell Therapy Manufacturing Facility.” The webinar, which included executives from Tenaya Therapeutics, Iovance, Kite Pharma, and Instil Bio, provided some great considerations and best practices for those of you who have chosen to take the plunge into building your own capacity.

89. Living Happily Ever After With Your Cell Therapy Facility: Where Do You Start? 9/20/2021

    In recent months, I watched an Endpoints News webinar entitled, “Strategies For Building A Cell Therapy Manufacturing Facility.” The webinar, which included executives from Tenaya Therapeutics, Iovance, Kite Pharma, and Instil Bio, provided some great considerations and best practices for those of you who have chosen to take the plunge into building your own capacity.

90. So, You're Building A Cell Therapy Facility: A Choose Your Own Adventure Story 9/20/2021

    It’s as timeless a tale as Cinderella and her glass slipper: A C&G company is born.